<DOC>
	<DOCNO>NCT02069977</DOCNO>
	<brief_summary>- To evaluate efficacy flexibly dose aripiprazole reduce serious behavioral problem Asian child adolescent diagnosis autism spectrum disorder , measure change baseline endpoint irritability subscale aberrant behavior checklist ( ABC-I ) . - To evaluate long-term safety tolerability flexibly dose aripiprazole treatment serious behavioral problem Asian child adolescent diagnosis autism spectrum disorder .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Aripiprazole</brief_title>
	<detailed_description>1 . Study design - Multi-national , Multi-center , 52 week open label , single arm design</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>6 17 year age . Meeting diagnostic criterion autistic disorder specify Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) , diagnosis corroborate Autism Diagnostic InterviewRevised ( ADIR ) diagnostic instrument demonstrate behavior tantrum , aggression , selfinjurious behavior , combination . Clinical Global Impressions ( CGI ) Severity subscale score ≥ 4 screen baseline . Aberrant Behavior Checklist ( ABC ) Irritability subscale score ≥18 screen baseline . Mental age ≥ 18 month . Women childbearing potential ( WOCBP ) use adequate method contraception WOCBP must negative serum urine pregnancy test . The patient and/or designate guardian ( ) caregiver ( ) able comprehend comply protocol requirement , opinion investigator consent participate signing informed consent form . Current diagnosis bipolar disorder , schizophrenia , major depressive disorder , Rett 's disorder , FragileX syndrome . History neuroleptic malignant syndrome . Significant risk commit suicide base history routine psychiatric status examination . History seizure past 1 year . History severe head trauma stroke History current evidence unstable medical condition Patient consider treatment resistant neuroleptic medication Patient consider treatment resistant aripiprazole Woman pregnant breastfeed ECG : QTc &gt; 475 msec Platelets ≤ 75,000/μL Hemoglobin ≤ 9 g/dL Neutrophils ≤ 1.0x10^3/μL Aspartate alanine transaminase ( AST ALT ) &gt; 3xULN Serum creatinine ≥ 2 mg/dL Patient weigh &lt; 15 kg Patient participate clinical trial within 4 week Patient determine require administration prohibit medication study period Patient condition determine investigator inappropriate clinical study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Autism</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Abilify</keyword>
</DOC>